⌘K

Login Start Free

Home/Filings/4/0001415889-24-023363

4//SEC Filing

Graef Thorsten 4

Accession 0001415889-24-023363

CIK 0001817241other

View on SEC.gov Company Profile

Filed

Sep 12, 8:00 PM ET

Accepted

Sep 13, 4:15 PM ET

Size

4.8 KB

Accession

0001415889-24-023363

Insider Transaction Report

Form 4

Period: 2024-09-12

Artiva Biotherapeutics, Inc.ARTV

Chief Medical Officer

Transactions

Award
Common Stock
2024-09-12+20,000→ 20,000 total

Footnotes (1)

[F1]Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan.

Documents

1 file

4
form4-09132024_040909.xmlPrimary

Issuer

Artiva Biotherapeutics, Inc.

CIK 0001817241

Entity typeother

Related Parties

1

filerCIK 0001581192

Filing Metadata

Form type: 4
Filed: Sep 12, 8:00 PM ET
Accepted: Sep 13, 4:15 PM ET
Size: 4.8 KB

View on SEC.gov